1. Lung resistance was measured by the interruptor method in fifteen patients during infusion of prostaglandin E2 or FZa, for termination of pregnancy.
M E T H O D S
The fifteen patients studied had been admitted to a double-blind clinical trial comparing the abortifacient properties of intravenous infusions of PGE, and PGF,,. All patients were between 11 and 18 weeks pregnant, were aged between 19 and 42 years (mean age 23.4 years); five were negro and ten were Caucasian. Of the eleven who were cigarette smokers, five smoked ten or more cigarettes daily, all of whom had experienced at least one attack of winter bronchitis in the past. Four patients had a family history of asthma, eczema or hayfever, but none suffered from asthma or any other disease of the lungs or heart. Smoking was allowed during the procedure. The decision to terminate pregnancy was taken in each case by the gynaecologist in charge as part of normal treatment; consent for the performance of the lung function tests was obtained after full explanation of their purpose. Intravenous infusion was started with 0.1 5 M-NaC1 and the basal readings were obtained. The prostaglandin infusion which had been randomly allocated to the patient was then started, the dose being increased at set intervals (Table 1) by doubling the rate of infusion, which was controlled by a constant infusion pump until abortion occurred. Before each change in infusion rate, and in some cases half an hour afterwards, readings of lung resistance (R,) were taken using an interruptor valve. The mean reading taken at the end of the half hour infusion of 0.15 M-NaC1 is referred to as the basal reading. In addition to the patients receiving PGEz and PGF,,, eleven patients between the ages of 15 and 30 years, who had been admitted for minor gynaecological complaints were studied to establish the variation in the method and normal variation in lung resistance over the same period of time as the patients receiving PGs. None had any history or evidence of heart or lung disease and none had been given an anaesthetic for at least 10 days. They were confined to bed all day and were allowed to smoke. Readings of lung resistance were taken at the same times and at the same intervals as the patients in the trial. Because of the nature and circumstances of a prostaglandin abortion measurement in a true control group was not practical. The interruptor valve used to measure lung resistance was similar to that described by Clements, Sharp, Johnson & Elam (1959) and consisted of a mouthpiece attached to an electrically driven rotating valve that interrupted the patients' airflow ten times a second. The mouthpiece pressure before and during airflow interruption was measured with a transducer whose output was amplified and recorded on paper moving at 25 mm/s. During the procedure the patient reclined in bed with her nose clipped, and breathed through the valve at rest for a minimum of three breaths. The lung resistance was calculated for each breath and the mean resistance with its standard deviation for each reading was obtained. The pressure in the mouthpiece when the valve was open (Fig. 1 calculated, the mouthpiece pressure having previously been calibrated for known airflows. During interruption the mouthpiece pressure rose (Pz -PI) and, as flow had ceased, Pz was considered to approximate to alveolar pressure. In this fashion the pressure difference between alveoli and mouth (AP) and airflow (3) were derived and resistance calculated both for inspiratory and expiratory flow, although only the former is given.
RESULTS

Efects of change inflow rate upon R,
At high rates of flow (n the V/AP relationship flattens off and therefore estimation of resistance should be made at the same rate of flow, but in practice this was not possible. Flow rates encountered during the investigation ranged from 0-2 to 0.9 l/s; the largest upward change in flow rate, from 0.39 to 0.69 l/s, occurred in a patient whose R, remained constant throughout the procedure, and the greatest fall in flow rate (0.66-0-37 l/s) occurred in a patient whose R1 became elevated during the infusion (Case 14). Of those patients whose lung resistance became elevated, flow rate fell during the procedure in six and rose in three. Values of V and AP from those three patients had a linear relationship, probably because the changes in flow were small, the largest being 0.21 l/s. 'r' and AP on inhalation for a number of subjects are given (Fig. 2) ; up to 0.75 l/s the relationship is reasonably constant.
The mean basal inspiration lung resistance for all patients was 3.72 (SD 1.34) cmH,O 1-1 s-' which does not differ significantly from that of the control group. Four, all of whom had experienced winter bronchitis and were heavy smokers, had elevated values for R,.
Effect of PGE2 infusion PGE, was received by patients 1-7 (Table 2) . A small increase in R, occurred in all but one patient after 2.5 pg/min for 30 min, which was statistically significant (PxO.05) in only two cases. Thereafter, a further increase in R, occurred in three patients after 5.0 pg/min for 4 h and it continued to rise on increasing the dose in two patients, and remained constant in one. The mean change from the basal reading on each occasion for all the patients was compared with the mean change of the control group at similar periods. There was a clear small but significant overall elevation in R, during the infusion ( Table 3) .
Effect of PGF,, infusion
PGF,, was received by patients 8-15 (Table 2) . Elevation of R, was observed in five patients over the course of the infusion, which occurred in four after infusion of 50 pg/min for 4 h and in one after infusion of 100 pg/min for a similar period. However, R, fell in two patients, after infusion of 5 pg/min for 4 h in both cases, and no change was observed in another patient. The degree of significance of the results was less compared with those obtained during PGE2 infusion due to the increased variance of the results. On one occasion the elevated level which h n had occurred early in the course of the treatment of patient 13 fell to normal when the infusion apparatus failed (4.90-2.03 cmH,O 1-l s-l) and immediately rose again when the infusion was started at the higher dose (2.03-5.4 cmH,O 1-l s-'). During infusion of prostaglandins E2 and F,, no patient complained of tightness in the chest or wheezing, nor was it detected clinically. Two patients receiving PGF,, (patients 10 and 13) complained of coughing and four of stuffiness of the nose. The variation in response of some of the patients to the infusions has been studied in relation to the factors in the history, and events occurring during the procedure. A past history or family history of allergic symptoms (eczema, hayfever, asthma, urticaria or drug allergy) was elicited from four patients, all of whom responded to their treatment with a rise in R,. This association however, was probably due to chance (P> 0.10, fourfold table test, Documenta Geigy Scientific Tables, 1970, pp. 109-123) . Smoking during the procedure could not be associated with a rise in R,, as it also occurred in non-smokers and did not occur in the controls who smoked ( P > 0.20, fourfold table test). Similarly there was no clear association between the changes in R,, and age, sex, race, induction to abortion interval or incidence of prostaglandininduced side effects.
Control subjects
Estimatiins of lung resistance were obtained at the same time intervals as those taken during the infusions of prostaglandins with the object of studying the variations in the method and any natural changes occurring over the course of the day in the absence of prostaglandin infusion.
The results are presented in Table 4 .
Although there were variations in the readings observed, none approached the order of the changes observed in the group receiving the prostaglandin infusions.
D I S C U S S I O N
The interruptor-valve method of studying lung resistance was chosen because of its simplicity in operation and the small amount of co-operation required of the subject. Originally attempts were made to collect data by means of the forced expiratory volume in 1 s and the peak flow rate but it was impossible to obtain the degree of co-operation required for these tests from patients who were often in pain and uncomfortable.
Lung resistance may be calculated without previous calibration by utilizing the alinear AP-p, relationship of the valve, which was designed to resemble that of the human bronchial tree. The relationship between recorded pressure difference and flow then becomes linear and resistance (R,) is calculated from the expression :
when Rapp. is the resistance of the apparatus.
Because values for resistance show considerable variation when they are obtained by this method (Lloyd &Wright, 1963) , possibly due to the failure of the bronchial tree to maintain a constant pressure/flow relationship at different lung volumes and airway calibre, it was not used. There is an alinear relationship between driving pressure and airflow, due to the effect of turbulence, so that a small increase in V may give rise to a disproportionate increase in AP. Thus a rise in palone may be represented by a rise in resistance. The results of this investigation were evaluated with this possibility in mind and it was concluded that the changes in flow that occurred did not materially affect the estimation of lung resistance (see Fig. 2 ). The term 'lung resistance' has been used to describe the values obtained by the interruptor valve, as they are higher than those obtained for airway resistance by other methods (Mead & Wittenberger, 1954) , and are higher than the results obtained from the group of females studied by Peslin (1967) by a similar interruptor technique (mean 2-28 cmH,O I-' s-I). The reason for this probably lies in the resistance of the valve itself, requiring increased respiratory effort to draw air through it and therefore increased rarefaction of iatrathoracic gas by the respiratory 24 A . P. Smith muscles at the point of interruption, but the results are consistent for each subject when repeated at different intervals providing large changes in flow rate do not occur. Inspiratory readings only were used, as those taken on expiration were more sensitive to changes in flow rate and showed more breath-to-breath variation. Experience in this laboratory has shown that changes in airway resistance measured by the body plethysmograph and by the interruptor valve are well correlated, although basal readings are higher, and increases in resistance are usually underestimated by the interruptor technique. It has been concluded from the results of this investigation that patients receiving both PGE, and PGF,, may develop a small but significant increase in lung resistance.
An increase in bronchial muscle tone during PGF,, infusion was expected as experiments on isolated human bronchial muscle showed that PGF,, is a bronchoconstrictor agent (Sweatman & Collier, 1968) . The rapidity of the changes observed in patient 13 would suggest an action primarily upon the bronchial muscle, but the nasal congestion noticed by four subjects, presumably due to mucosal oedema, could possibly be analogous to changes occurring in the bronchial wall. PGE, relaxes bronchial smooth muscle when applied directly to the human bronchus (Cuthbert, 1971) or when given intravenously to animals (Rosenthale et al., 1968) except the cat (Main, 1964) when bronchoconstriction occurs. Vane and his colleagues (Ferriera & Vane, 1967; Piper, Vane & Wyllie, 1970) have shown that infused prostaglandins, especially E-series PGs, are removed and degraded on passing through the lung. It is likely therefore that the bronchial muscle was being perfused by blood which contained metabolites, possibly with bronchoconstrictor properties, and it is noteworthy that there are no reports available about the nature of the uterine constrictor agents that occur as a result of PG infusion. Possibly the unexplained variation in response to PG infusion reflects the differing abilities of the enzyme systems of different individuals to handle large doses of PGs presented to them.
In conditions where airways narrowing already exists, such as bronchial asthma or chronic bronchitis, it may be wise to consider alternative means of terminating pregnancy, particularly in the former condition where exaggerated sensitivity to other humoral mediators (e.g. histamine) already exists.
It may be concluded that PG infusions of the order described were not harmful in patients with normal lungs, despite the changes in lung resistance recorded. The effect of PGE, in raising bronchial muscle tone is of great interest and raises the question of the nature of the uterine constrictor agents that occur as a result of PG infusion. 
